RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA
Clinical trials for RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo trial offers hope for tough blood cancers
Disease control OngoingThis study is testing a new drug called epcoritamab to see if it is safe and effective for people with certain hard-to-treat blood cancers. It is for adults with chronic lymphocytic leukemia (CLL) or Richter's syndrome that has come back or not responded to other treatments. The …
Matched conditions: RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Genmab • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New 'Quad' antibody tested as last hope for tough blood cancers
Disease control OngoingThis early-stage study is testing a new, experimental drug called GNC-035 in adults with chronic lymphocytic leukemia and other blood cancers that have come back or stopped responding to standard treatments. The main goals are to find a safe dose and see if the drug shows any sig…
Matched conditions: RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC